Top Tweets for #CoLyM

about 2 years ago

Last day of @TheIACH #COLYM. @MadihaIqbal13 contemporary approach to MCL #lymsm

0

23

4

3

2K

about 2 years ago

Matt Lunning @lymphomaphilia kick starting T-cell lymphoma session at the @TheIACH #colym meetings #lymsm

0

10

1

962

about 2 years ago

Always great to hear @AndyD1036 speak. Today about 1st line DLBCL and bispecific @TheIACH #colym #lymsm

0

20

6

0

2K

about 2 years ago

Learnt a lot in the fabulous Hodgkin session 🙏🙏🙏 @awandoc @graham74GC @NGhoshMD @TheIACH #COLYM meetings in Paris

0

10

1

0

3K

about 2 years ago

Up now @NGhoshMD in the @TheIACH #colym meeting talking about salvage therapy in #Hodgkin

0

13

3

0

2K

about 2 years ago

Up now @graham74GC in the @TheIACH #colym meeting talking about older unfit #Hodgkin

1

9

2

1

1K

about 2 years ago

At the @TheIACH #COLYM session Prof Wendy Osborne discussed Follicular lymphoma @StefanoLuminari @AnnaSureda5 #lymsm

0

12

0

908

almost 3 years ago

#IACH23 | @amgarciasancho discussed cellular therapy as the best therapy for RR #MCL using promising insights from ZUMA-2, TRANSCEND NHL 001, and TARMAC trials. #lymsm #lymphoma #COLYM #TheIACH

lymphomahub's tweet photo. #IACH23 | @amgarciasancho discussed cellular therapy as the best therapy for RR #MCL using promising insights from ZUMA-2, TRANSCEND NHL 001, and TARMAC trials. #lymsm #lymphoma #COLYM #TheIACH https://t.co/7zA1SYQX9L

1

10

4

2K

almost 3 years ago

#IACH23 | @MarekTrnenyDr at Charles University discussed front-line consolidation with high-dose therapy and auto-HCT and post-transplant R maintenance: should this approach be abanded in MCL? #lymsm #lymphoma #COLYM #TheIACH

lymphomahub's tweet photo. #IACH23 | @MarekTrnenyDr at Charles University discussed front-line consolidation with high-dose therapy and auto-HCT and post-transplant R maintenance: should this approach be abanded in MCL? #lymsm #lymphoma #COLYM #TheIACH https://t.co/FVG1VONQKT

0

7

3

1

2K

almost 3 years ago

#IACH23 | #COLYM Plenary Lecture | @DrMiguelPerales @MSKCancerCenter presented an overview of the recent advances in allogeneic CAR T. Safety and efficacy of various novel CAR T and CAR NK cell therapies for #MultipleMyeloma, T- and B-cell malignancies, and solid tumors were discussed. #lymsm #lymphoma #TheIACH

lymphomahub's tweet photo. #IACH23 | #COLYM Plenary Lecture | @DrMiguelPerales @MSKCancerCenter presented an overview of the recent advances in allogeneic CAR T. Safety and efficacy of various novel CAR T and CAR NK cell therapies for #MultipleMyeloma, T- and B-cell malignancies, and solid tumors were discussed. #lymsm #lymphoma #TheIACH

0

23

8

6

4K

Stefano Luminari, MD @StefanoLuminari

almost 3 years ago

#IACH23 | @TillyHerve at the University of Rouen debated no for R-CHOP as SOC for the first-line therapy in DLBCL. He presented promising data from the POLARIX trial of Pola-R-CHP in DLBCL. #lymsm #lymphoma #COLYM #TheIACH

lymphomahub's tweet photo. #IACH23 | @TillyHerve at the University of Rouen debated no for R-CHOP as SOC for the first-line therapy in DLBCL. He presented promising data from the POLARIX trial of Pola-R-CHP in DLBCL. #lymsm #lymphoma #COLYM #TheIACH https://t.co/yFaFd7BNx8

0

16

4

2

2K

almost 3 years ago

Best team leading IACH dayS in paris #colym #comydal #mpncod @AnnaSureda5 @Dr_AmerZeidan @Mohty_EBMT and Arnon Nagler

0

4

0

628

Cristina Garcia Herce @crisgarciaherce

almost 3 years ago

Exciting discussion by @DrMiguelPerales on the promising potential of allogeneic CAR T-cell therapy! #IACH23 #COLYM @TheIACH

crisgarciaherce's tweet photo. Exciting discussion by @DrMiguelPerales on the promising potential of allogeneic CAR T-cell therapy! #IACH23 #COLYM @TheIACH https://t.co/JPwDWS0fNA

0

12

3

0

1K

almost 3 years ago

#IACH23| @DrMiguelPerales @MSKCancerCenter discussed an overview of when to consider allogeneic HCT in patients with classical Hodgkin lymphoma previously treated with BV and CKI. #lymsm #lymphoma #COLYM #TheIACH

lymphomahub's tweet photo. #IACH23| @DrMiguelPerales @MSKCancerCenter discussed an overview of when to consider allogeneic HCT in patients with classical Hodgkin lymphoma previously treated with BV and CKI. #lymsm #lymphoma #COLYM #TheIACH https://t.co/8aNRRVin9Q

0

9

4

1

2K

almost 3 years ago

Great @TheIACH #colym meeting. Thanks to inspiring @Mohty_EBMT. Grateful to cochairs @AnnaSureda5 @StefanoLuminari @MKD_BMT. 🙏🙏 to experts donating time @awandoc @DrMiguelPerales @DrChrisPFox @graham74GC @sairah__ahmed @mshadman @JulioChavezMD @Evadodo23 @doctorpemm et al

IACH

@TheIACH

almost 3 years ago

Our last evening in Paris before tomorrow’s program see you all in the morning! 🌟⭐️💫✨ @Mohty_EBMT @nagler_EBMT @melmehdi @AnnaSureda5 @StefanoLuminari @Dr_AmerZeidan @doctorpemm @mpdrc @Santin13Valeria @harrisoncn1

0

21

9

0

9K

0

27

2

0

5K